公司活动安排 - 公司管理层将于11月21日东部时间上午11点在纽约参加Canaccord Genuity医疗技术、诊断及数字健康与服务论坛并进行演讲[1] 投资者关系信息 - 活动提供实时及回放网络直播 可通过公司官网投资者关系栏目访问[2] - 网络回放将在活动结束后保留至少30天[2] 公司业务定位 - 公司使命是通过早期检测实现癌症治愈 专注于利用下一代测序技术、大规模临床研究及先进机器学习技术减轻全球癌症负担[3] - 核心技术为靶向甲基化检测平台 支持筛查与精准肿瘤学全程管理 包括多癌种早期检测、风险分层、微小残留病灶监测及复发监控[3] 公司运营布局 - 总部位于加利福尼亚州门洛帕克 在华盛顿特区、北卡罗来纳州和英国设有分支机构[3]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________ FORM 10-Q ___________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | |----------------------------------------------- ...

NEWS RELEASE Exhibit 99.1 GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update Second Quarter Revenue Grew 43% Year-Over-Year to $32.0 Million Portfolio Prioritization and Corporate Restructure Extends Cash Runway into 2028 MENLO PARK, Calif. — Aug. 13, 2024 — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the second quarter 2024. Revenue in the second quarter was ...